Correlation Between Rigel Pharmaceuticals and Mosaic Immunoengineerin
Can any of the company-specific risk be diversified away by investing in both Rigel Pharmaceuticals and Mosaic Immunoengineerin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rigel Pharmaceuticals and Mosaic Immunoengineerin into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rigel Pharmaceuticals and Mosaic Immunoengineering, you can compare the effects of market volatilities on Rigel Pharmaceuticals and Mosaic Immunoengineerin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rigel Pharmaceuticals with a short position of Mosaic Immunoengineerin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rigel Pharmaceuticals and Mosaic Immunoengineerin.
Diversification Opportunities for Rigel Pharmaceuticals and Mosaic Immunoengineerin
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Rigel and Mosaic is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Rigel Pharmaceuticals and Mosaic Immunoengineering in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mosaic Immunoengineering and Rigel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rigel Pharmaceuticals are associated (or correlated) with Mosaic Immunoengineerin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mosaic Immunoengineering has no effect on the direction of Rigel Pharmaceuticals i.e., Rigel Pharmaceuticals and Mosaic Immunoengineerin go up and down completely randomly.
Pair Corralation between Rigel Pharmaceuticals and Mosaic Immunoengineerin
Given the investment horizon of 90 days Rigel Pharmaceuticals is expected to generate 0.61 times more return on investment than Mosaic Immunoengineerin. However, Rigel Pharmaceuticals is 1.65 times less risky than Mosaic Immunoengineerin. It trades about 0.35 of its potential returns per unit of risk. Mosaic Immunoengineering is currently generating about 0.13 per unit of risk. If you would invest 1,420 in Rigel Pharmaceuticals on September 2, 2024 and sell it today you would earn a total of 1,341 from holding Rigel Pharmaceuticals or generate 94.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rigel Pharmaceuticals vs. Mosaic Immunoengineering
Performance |
| Timeline |
| Rigel Pharmaceuticals |
| Mosaic Immunoengineering |
Rigel Pharmaceuticals and Mosaic Immunoengineerin Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rigel Pharmaceuticals and Mosaic Immunoengineerin
The main advantage of trading using opposite Rigel Pharmaceuticals and Mosaic Immunoengineerin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rigel Pharmaceuticals position performs unexpectedly, Mosaic Immunoengineerin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mosaic Immunoengineerin will offset losses from the drop in Mosaic Immunoengineerin's long position.| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
| Mosaic Immunoengineerin vs. Cell Source | Mosaic Immunoengineerin vs. Marizyme | Mosaic Immunoengineerin vs. ACRO Biomedical Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |